Innoviva, Inc. (INVA)
23.39
-0.25
(-1.06%)
USD |
NASDAQ |
Feb 20, 16:00
23.38
0.00 (0.00%)
After-Hours: 20:00
Innoviva Profit Margin (Quarterly) : 80.81% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Merck & Co., Inc. | 18.06% |
| Nektar Therapeutics | -301.3% |
| Regeneron Pharmaceuticals, Inc. | 21.74% |
| Oramed Pharmaceuticals, Inc. | -- |
| Theravance Biopharma, Inc. | 18.08% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 17.06% |
| Return on Assets | 9.67% |
| Return on Invested Capital | 10.86% |
| Gross Profit Margin (Quarterly) | 67.87% |
| Operating Margin (Quarterly) | 31.08% |
| Return on Net Operating Assets | 34.83% |